Biotech RadarJobs updated

COMPANY

Comanche Biopharma

HQ: Concord, MA source · comanchebiopharma.com ↗

Clinical Phase 1

Location: Concord, MA · source · Jan 17, 2024

Profile checked Oct 10, 2026

Keywords: sFlt1 Mediated Preterm Preeclampsia Preeclampsia Preterm Preeclampsia CBP-4888

2Trials (company is sponsor)

Timeline

  1. Trial start Phase 1: A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Participants With Preterm Preeclampsia and Their Children up to 24 Months source ↗
  2. Trial start Early phase 1: Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 2

RecordTitlePhaseStatusStartPrimary completion
NCT07282171A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Participants With Preterm Preeclampsia and Their Children up to 24 MonthsPhase 1RecruitingFeb 26, 2025Mar 31, 2027 (estimated)
NCT05881993Study of CBP-4888 in Healthy, Non-Pregnant Female SubjectsEarly phase 1CompletedMay 22, 2023May 22, 2024 (actual)

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

Feedback